Related Experiment Videos
Adjuvant therapy of cutaneous melanoma
Lancet (London, England)
|February 3, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Five-year survival with tebentafusp in metastatic uveal melanoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
IO102-IO103 immune-modulatory cancer vaccine and pembrolizumab in melanoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
The role of the molecular tumor board: learnings from the ROME trial.
NPJ precision oncology·2026
Randomized, double-blind, phase III LEAP-003 study of first-line lenvatinib plus pembrolizumab versus placebo plus pembrolizumab for unresectable or metastatic melanoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Neoadjuvant intralesional targeted immunocytokines (daromun) in stage III melanoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Risk of transmission of amyloid β pathology via transfused blood products.
Lancet (London, England)·2026